Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Pediatric

Charting the Course for Next Generation Pediatric Lupus Therapies

Monday, October 27, 2025
4:00 PM – 5:00 PM Central Time

    Moderator(s)

  • EO

    Ekemini Ogbu, MD, MSc

    Cincinnati Children's Hospital Medical Center
    Cincinnati, OH, United States

    Disclosure information not submitted.

  • Joyce Hui-Yuen, MD, MS

    North Shore LIJ Health System
    Great Neck, NY, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

    • Session Coordinator(s)

  • Joyce Hui-Yuen, MD, MS

    North Shore LIJ Health System
    Great Neck, NY, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

There will be two presentations: 1. Current barriers to medication development in pediatrics and 2. The role of adult lupus trials in supporting pediatric lupus trials. Given that pediatric drug development requires success of the adult drug, developing programs for strategic alignment is helpful to advance medication access in children. This could include inclusion of adolescents in adult studies, alignment of outcome measures, and study designs.

Learning Objectives:

  • Identify barriers to medication development in children with lupus
  • Review the impact of barriers on medication access for children with lupus
  • Formulate strategies to facilitate the extrapolation of the pharmacokinetic and pharmacodynamic estimates from adult to pediatric studies

Presentations:

  • 4:00 PM – 4:30 PM Central Time
    Current Barriers to Medication Development in Pediatrics

    Speaker: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center

  • 4:30 PM – 5:00 PM Central Time
    Role of Adult Lupus Trials in Supporting Pediatric Lupus Trials

    Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center